rs807624

This is a regulatory region variant variant.

GWAS Catalog Trait Associations (7)

Genome-wide significant associations (p < 5×10⁻⁸) from the NHGRI-EBI GWAS Catalog.

serum creatinine amount

Allele T
OR 0.02
p 9.0e-50
N 928,679
Large GWAS
multi-ancestry
Verma A et al. Diversity and scale: Genetic architecture of 2068 traits in the VA Million Veteran Program. Science (new York, N.y.) 385(6706):eadj1182 (2024)
Allele T
OR 0.02
p 5.0e-18
N 602,615
Major Consortium StudyLarge GWAS
multi-ancestry
Allele T
OR 0.02
p 4.0e-39
N 394,642
Large GWAS
European

glomerular filtration rate

Allele T
OR 14.79
p 2.0e-49
N 1,508,659
Large GWAS
multi-ancestry
Allele T
OR 0.00
p 1.0e-21
N 1,004,040
Large GWAS
European
Allele T
OR 0.00
p 8.0e-31
N 765,348
Large GWAS
multi-ancestry
Verma A et al. Diversity and scale: Genetic architecture of 2068 traits in the VA Million Veteran Program. Science (new York, N.y.) 385(6706):eadj1182 (2024)
Allele T
OR 0.02
p 1.0e-18
N 571,227
Major Consortium StudyLarge GWAS
multi-ancestry
Allele T
OR 0.33
p 9.0e-10
N 188,993
Major Consortium StudyLarge GWAS
multi-ancestry

urate measurement

Allele T
OR 0.02
p 1.0e-20
N 454,183
Meta-analysisLarge GWAS
European

kidney volume

Monteiro-Martins S et al. Genetic screens of imaging-derived kidney volumes identify genes linked to kidney function. Kidney International 109(2):365-378 (2026)
Allele G
OR 0.05
p 1.0e-15
N 38,816
Large GWAS
European

Nephroblastoma

Allele A
OR 1.33
p 1.0e-14
N 2,636
Large GWAS
European

blood urea nitrogen amount

Allele G
OR 0.00
p 6.0e-14
N 852,680
Large GWAS
European

gout

Major TJ et al. A genome-wide association analysis reveals new pathogenic pathways in gout. Nature Genetics 56(11):2392-2406 (2024)
Allele T
OR 0.96
p 1.0e-10
N 1,011,521
Large GWAS
European

This variant is in our database but has no known associations or PRS memberships yet.

Gene information from NCBI Gene. Variant classifications from ClinVar.

Community Wiki

No community notes yet for this variant. Sign in to start one.

Comments

Sign in to join the discussion.

Loading comments…